Last Updated: 04/06/2026

Stablepharma

Bristol

Founded 2012

Thermostable vaccine platform eliminating cold chain dependency

Stablepharma is a clinical-stage biotechnology company developing fridge-free vaccines and biologicals using.

Its technology reformulates temperature-sensitive products into thermostable formulations that remain potent without refrigeration.

The technology addresses cold chain failure, which the WHO estimates causes over 50% of annual global vaccine wastage.

Its lead candidate, a fridge-free tetanus and diphtheria booster vaccine, entered Phase 1 clinical trials in 2025 following MHRA approval.

Is this your company?

Claim this page to receive a verified badge and keep your profile up to date.

Member of